Literature DB >> 22739419

Blood pressure categories and long-term risk of cardiovascular disease according to age group in Japanese men and women.

Akira Fujiyoshi1, Takayoshi Ohkubo, Katsuyuki Miura, Yoshitaka Murakami, Shin-Ya Nagasawa, Tomonori Okamura, Hirotsugu Ueshima.   

Abstract

Blood pressure (BP) categories defined by systolic BP (SBP) and diastolic BP (DBP) are commonly used. However, the BP category-specific risk of cardiovascular disease (CVD) has not been thoroughly investigated in different age groups. The aim of this study was to assess long-term CVD risk and its impact according to BP categories and age group. Pooling individual data from 10 cohorts, we studied 67 309 Japanese individuals (40-89 years old) who were free of CVD at baseline: we categorized them as belonging to three age groups: 'middle-aged' (40-64 years), 'elderly' (65-74 years) and 'very elderly' (75-89 years). BP was classified according to the 2009 Japanese Society of Hypertension Guidelines. Cox models were used to estimate adjusted hazard ratios for CVD deaths. We observed 1944 CVD deaths over a mean follow-up of 10.2 years. In all age groups, the overall relationship between BP category and CVD risk was positive, with a greater strength observed for younger age groups. We observed a trend of increased risk from SBP/DBP ≥ 130/85 mm Hg in the very elderly, and a significant increase from SBP/DBP ≥ 120/80 mm Hg in the other age groups. The population attributable fractions (PAFs) of CVD death in reference to the SBP/DBP<120/80 mm Hg category ranged from 23.4% in the very elderly to 60.3% in the middle-aged. We found an overall graded increase in CVD risk with higher BP category in the very elderly. The PAFs suggest that keeping BP levels low is an important strategy for primary CVD prevention, even in an elderly population.

Entities:  

Mesh:

Year:  2012        PMID: 22739419     DOI: 10.1038/hr.2012.87

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  38 in total

1.  Association between serum prostate-specific antigen level and diabetes, obesity, hypertension, and the laboratory parameters related to glucose tolerance, hepatic function, and lipid profile: implications for modification of prostate-specific antigen threshold.

Authors:  Minoru Kobayashi; Tomoya Mizuno; Hideo Yuki; Tsunehito Kambara; Hironori Betsunoh; Akinori Nukui; Hideyuki Abe; Yoshitatsu Fukabori; Masahiro Yashi; Takao Kamai
Journal:  Int J Clin Oncol       Date:  2019-08-22       Impact factor: 3.402

2.  Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017.

Authors:  Makoto Kinoshita; Koutaro Yokote; Hidenori Arai; Mami Iida; Yasushi Ishigaki; Shun Ishibashi; Seiji Umemoto; Genshi Egusa; Hirotoshi Ohmura; Tomonori Okamura; Shinji Kihara; Shinji Koba; Isao Saito; Tetsuo Shoji; Hiroyuki Daida; Kazuhisa Tsukamoto; Juno Deguchi; Seitaro Dohi; Kazushige Dobashi; Hirotoshi Hamaguchi; Masumi Hara; Takafumi Hiro; Sadatoshi Biro; Yoshio Fujioka; Chizuko Maruyama; Yoshihiro Miyamoto; Yoshitaka Murakami; Masayuki Yokode; Hiroshi Yoshida; Hiromi Rakugi; Akihiko Wakatsuki; Shizuya Yamashita
Journal:  J Atheroscler Thromb       Date:  2018-08-22       Impact factor: 4.928

Review 3.  Future possibilities for artificial intelligence in the practical management of hypertension.

Authors:  Hiroshi Koshimizu; Ryosuke Kojima; Yasushi Okuno
Journal:  Hypertens Res       Date:  2020-07-13       Impact factor: 3.872

4.  Associations of blood pressure categories defined by 2017 ACC/AHA guidelines with mortality in China: Pooled results from three prospective cohorts.

Authors:  Na Liu; Jae Jeong Yang; Ruiwei Meng; Xiong-Fei Pan; Xiaomin Zhang; Meian He; Honglan Li; Yu-Tang Gao; Yong-Bing Xiang; Xiao-Ou Shu; Wei Zheng; Tangchun Wu; Danxia Yu; An Pan
Journal:  Eur J Prev Cardiol       Date:  2019-07-09       Impact factor: 7.804

5.  Blood pressure, low-density lipoprotein cholesterol, and incidences of coronary artery disease and ischemic stroke in Japanese: the Suita study.

Authors:  Rumi Tsukinoki; Tomonori Okamura; Makoto Watanabe; Yoshihiro Kokubo; Aya Higashiyama; Kunihiro Nishimura; Misa Takegami; Yoshitaka Murakami; Akira Okayama; Yoshihiro Miyamoto
Journal:  Am J Hypertens       Date:  2014-04-08       Impact factor: 2.689

Review 6.  Strategies for improving the treatment and control of hypertension in Japan.

Authors:  Atsushi Sakima; Tetsutaro Matayoshi; Hisatomi Arima
Journal:  J Hum Hypertens       Date:  2022-06-03       Impact factor: 3.012

7.  Systolic blood pressure and cardiovascular mortality in middle-aged and elderly adults - The Singapore Chinese Health Study.

Authors:  Angela S Koh; Mohammad Talaei; An Pan; Renwei Wang; Jian-Min Yuan; Woon-Puay Koh
Journal:  Int J Cardiol       Date:  2016-06-14       Impact factor: 4.164

Review 8.  Improving obesity and blood pressure.

Authors:  Masami Tanaka
Journal:  Hypertens Res       Date:  2019-10-25       Impact factor: 3.872

Review 9.  Asian management of hypertension: Current status, home blood pressure, and specific concerns in Japan.

Authors:  Tomoyuki Kabutoya; Satoshi Hoshide; Kazuomi Kario
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-10-17       Impact factor: 3.738

10.  Impacts of the urinary sodium-to-potassium ratio, sleep efficiency, and conventional risk factors on home hypertension in a general Japanese population.

Authors:  Takumi Hirata; Mana Kogure; Naho Tsuchiya; Ken Miyagawa; Akira Narita; Kotaro Nochioka; Akira Uruno; Taku Obara; Tomohiro Nakamura; Naoki Nakaya; Hirohito Metoki; Masahiro Kikuya; Junichi Sugawara; Shinichi Kuriyama; Ichiro Tsuji; Shigeo Kure; Atsushi Hozawa
Journal:  Hypertens Res       Date:  2021-02-15       Impact factor: 3.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.